Kun Lv
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 10%
- Immune cells in cancer
Papers in
-
- Cancer-related molecular mechanisms research 16
- MicroRNA in disease regulation 8
-
- RNA modifications and cancer 18
- RNA Research and Splicing 10
- Circular RNAs in diseases 6
- Co-authors
- Mengying Y. Zhang (21 shared papers)Xueqin Li (16 shared papers)Hui Yang (21 shared papers)Min Zhong (11 shared papers)Qifeng Suo (5 shared papers)Xiaolong Zhu (16 shared papers)Ying Ying Zhang (5 shared papers)Weiya Pei (7 shared papers)
In The Last Decade
Kun Lv
68 papers receiving 2.1k citations
Kun Lv's Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 678
- Immunology 427
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 242
- Cardiology and Cardiovascular Medicine 143
Countries citing papers authored by Kun Lv
This map shows the geographic impact of Kun Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Lv more than expected).
Fields of papers citing papers by Kun Lv
This network shows the impact of papers produced by Kun Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Lv. The network helps show where Kun Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Kun Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 212 | |
| 2 | 2013 | 167 | |
| 3 | M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2/HIF-1α axis mediated metabolic reprogramming of macrophages Hit paper breakdown → | 2023 | 112 |
| 4 | 2017 | 90 | |
| 5 | Multitargeted Immunomodulatory Therapy for Viral Myocarditis by Engineered Extracellular Vesicles Hit paper breakdown → | 2024 | 89 |
| 6 | 2016 | 89 | |
| 7 | 2021 | 81 | |
| 8 | Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer Hit paper breakdown → | 2024 | 71 |
| 9 | 2021 | 62 | |
| 10 | 2017 | 55 | |
| 11 | 2024 | 49 | |
| 12 | 2024 | 48 | |
| 13 | 2024 | 46 | |
| 14 | 2018 | 43 | |
| 15 | 2020 | 39 | |
| 16 | 2021 | 39 | |
| 17 | 2020 | 37 | |
| 18 | 2020 | 37 | |
| 19 | 2012 | 35 | |
| 20 | 2011 | 34 |
About Kun Lv
Kun Lv is a scholar working on Cancer Research, Molecular Biology, Immunology, Cardiology and Cardiovascular Medicine and Genetics, having authored 69 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), Cancer-related molecular mechanisms research (16 papers), RNA Research and Splicing (10 papers), MicroRNA in disease regulation (8 papers), Ferroptosis and cancer prognosis (7 papers), Circular RNAs in diseases (6 papers), Viral Infections and Immunology Research (6 papers) and Galectins and Cancer Biology (5 papers). The work is most often cited by research in Cancer Research (678 citations), Immunology (427 citations), Molecular Biology (1.1k citations), Pulmonary and Respiratory Medicine (242 citations) and Cardiology and Cardiovascular Medicine (143 citations). Kun Lv has collaborated with scholars based in China, Ireland and Japan. Frequent co-authors include Mengying Y. Zhang, Xueqin Li, Hui Yang, Min Zhong, Qifeng Suo, Xiaolong Zhu, Ying Ying Zhang, Weiya Pei, Yingying Zhang and Mingzhe Ma. Their work appears in journals such as European Journal of Pharmacology, Journal of Cellular and Molecular Medicine, International Journal of Molecular Medicine, Cancer Cell International and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.